advertisement

Oculus

14 Costing studies; pharmacoeconomics (15)

Showing records 1 to 15

Display all abstracts in classification 14 Costing studies; pharmacoeconomics

Search within classification 14 Costing studies; pharmacoeconomics
90617 Selective laser trabeculoplasty vs. topical medications for step-up treatment in primary open angle glaucoma: comparing clinical effectiveness, quality of life and cost-effectiveness
Yong MH
Medical Journal of Malaysia 2020; 75: 342-348
90098 Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma
Gupta D
Ophthalmology. Glaucoma 2020; 0:
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Yamada M
Journal of Medical Economics 2020; 23: 1293-1301
90089 The cost and quality of life impact of glaucoma in Tanzania: An observational study
Murdoch I
PLoS ONE 2020; 15: e0232796
90617 Selective laser trabeculoplasty vs. topical medications for step-up treatment in primary open angle glaucoma: comparing clinical effectiveness, quality of life and cost-effectiveness
Che Hamzah J
Medical Journal of Malaysia 2020; 75: 342-348
90089 The cost and quality of life impact of glaucoma in Tanzania: An observational study
Smith AF
PLoS ONE 2020; 15: e0232796
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Nakano T
Journal of Medical Economics 2020; 23: 1293-1301
90098 Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma
Ehrlich JR
Ophthalmology. Glaucoma 2020; 0:
90089 The cost and quality of life impact of glaucoma in Tanzania: An observational study
Baker H
PLoS ONE 2020; 15: e0232796
90098 Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma
Newman-Casey PA
Ophthalmology. Glaucoma 2020; 0:
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Matsuda H
Journal of Medical Economics 2020; 23: 1293-1301
90098 Cost-Related Medication Nonadherence in a Nationally Representative US Population with Self-Reported Glaucoma
Stagg B
Ophthalmology. Glaucoma 2020; 0:
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Kim SW
Journal of Medical Economics 2020; 23: 1293-1301
90089 The cost and quality of life impact of glaucoma in Tanzania: An observational study
Shilio B; Dhalla K
PLoS ONE 2020; 15: e0232796
90620 Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Takagi Y
Journal of Medical Economics 2020; 23: 1293-1301

Issue 21-3

Change Issue


advertisement

Oculus